Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.Titlenab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial.AuthorsGoldstein, David; El-Maraghi, Robert Hassan; Hammel, Pascal; Heinemann, Volker; Kunzmann, Volker; Sastre, Javier; Scheithauer, Werner; Siena, Salvatore; Tabernero, Josep; Teixeira, Luis; Tortora, Giampaolo; Van Laethem, Jean-Luc; Young, Rosemary; Penenberg, Darryl Neil; Lu, Brian; Romano, Alfredo; Von Hoff, Daniel DPublicationJNCI: Journal of the National Cancer Institute, 2015, Vol 107, Issue 2, pN.PAGISSN0027-8874Publication typeJournal ArticleDOI10.1093/jnci/dju413